RUMOURS circulating on social media suggest that those exposed to more particles of the coronavirus have a higher viral load and become sicker than other infected people. But the relationship between infection and severity may be more complex in covid-19 than in other respiratory illnesses.

The average number of viral particles needed to establish an infection is known as the infectious dose. We don\'t know what this is for covid-19 yet, but given how rapidly it is spreading, it is probably relatively low -- around a few hundred or thousand particles, says Willem van Schaik at the University of Birmingham, UK.

Viral load, meanwhile, relates to the number of viral particles carried by an individual and shed into their environment. "The viral load is a measure of how bright the fire is burning in an individual, whereas the infectious dose is the spark that gets that fire going," says Edward Parker at the London School of Hygiene & Tropical Medicine. If you have a high viral load, you are more likely to infect others, because you may be shedding more virus particles. Yet for covid-19, it doesn\'t necessarily follow that a higher viral load will lead to more severe symptoms.

For instance, health workers investigating the outbreak in the Lombardy region of Italy looked at more than 5000 infected people and found no difference in viral load between those with covid-19 symptoms and those without ([arxiv.org/abs/2003.09320](http://arxiv.org/abs/2003.09320){#interrefs10}).

Similarly, when doctors at the Guangzhou Eighth People\'s Hospital in China took throat swabs from 94 covid-19 patients, starting on the day they became ill and finishing when no virus could be detected, they found no clear difference in viral load between those with milder cases and those who had more severe symptoms (*medRxiv*, doi.org/dqbr).

Although it is difficult to draw firm conclusions at this stage, such studies "may impact our assumptions about whether a high number of viral particles predisposes to a more serious disease", says van Schaik.

However, a study of people hospitalised with covid-19 in Nanchang, China, found a strong association between severity and the amount of virus present in the nose (*The Lancet Infectious Diseases*, doi.org/dqrr). "Those with more severe disease had a higher level of virus replication, although we have no evidence to relay the initial exposure dose to disease outcome," says Leo Poon at the University of Hong Kong, who was involved in the study. "That rumour is still an open question to me."

It is early days, but if the infectious dose doesn\'t correlate with the severity of symptoms, this would mark covid-19 out as different to some other infections. For influenza, a higher infectious dose has been associated with worse symptoms. This has been tested by exposing volunteers to escalating doses of influenza virus in a controlled setting and carefully monitoring them over several weeks. Covid-19 is unlikely to be tested in a similar way, given its severity.

Animals infected with higher doses of the SARS and MERS coronaviruses also experienced worse outcomes, says van Schaik.

Even if the infectious dose isn\'t related to disease severity, it still pays to minimise our exposure to the virus because this will reduce our chances of falling ill in the first place. "Any measures we can take to avoid infection are worth taking," says Parker.
